Clinical Trial Update: Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for neoadjuvant Inetetamab with pertuzumab and paclitaxel/carboplatin in locally advanced breast cancer is reported, with status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Inetetamab (inetetamab)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Locally Advanced Breast Cancer, Chemotherapy Effect | Phase 2 | Status: UNKNOWN